Healthcare

Johnson & Johnson files lawsuit against Biden administration

July 19, 2023 06:07 AM AEST| By Invezz

Johnson & Johnson (NYSE: JNJ) is in focus today after the pharmaceutical behemoth filed a lawsuit against the Biden Administration in a federal district court. Here’s why J&J sued the Government In its complaint, the multinational argue...

Eli Lilly is buying Dice Therapeutics for $2.4 billion

June 21, 2023 12:15 AM AEST| By Invezz

Dice Therapeutics Inc (NASDAQ: DICE) opened more than 35% up this morning after Eli Lilly & Co (NYSE: LLY) said it will buy the immunology company for $2.4 billion. Dice stock up on the all-cash agreement The all-cash agreement values each share...

Francis deSouza just resigned as the CEO of Illumina Inc

June 12, 2023 04:14 AM AEST| By Invezz

Illumina Inc (NASDAQ: ILMN), on Sunday, said its board has accepted resignation from CEO Francis deSouza who’s been leading the gene sequencing company since 2016. Charles Dadswell named interim CEO The biotech giant has already started looking...

Biogen inches closer to FDA approval for its Alzheimer’s drug

June 11, 2023 04:33 AM AEST| By Invezz

Shares of Biogen Inc (NASDAQ: BIIB) gained nearly 10% in extended hours after the biotech firm edged closer to winning FDA approval for its Alzheimer’s drug. FDA panel greenlights Biogen’s Leqembi Late on Friday, advisory committee of the...

Merck just sued the Biden administration: find out why

June 07, 2023 01:12 AM AEST| By Invezz

Merck & Co Inc (NYSE: MRK) is in focus this morning after the pharmaceutical giant sued the Biden administration in a federal district court. Here’s what inspired the lawsuit In its complaint, the multinational took on “IRA” ...

Ocugen stock price plummeted: dead cat bounce can’t be ruled out

May 25, 2023 05:28 AM AEST| By Invezz

Ocugen (NASDAQ: OCGN) stock price plunged hard on Wednesday after the company unveiled more plans to dilute shareholders. The penny stock retreated to a low of $0.440, the lowest point since 2020. In all, the shares have plunged by over 99% from the...

Eli Lilly stock price forecast ahead of obesity drug approval

May 25, 2023 12:32 AM AEST| By Invezz

Eli Lilly & Co (NYSE: LLY) has rallied over the past three months but a Bank of America analyst says it’s not out of room to run just yet. Lilly stock should be worth $500 Geoff Meacham raised his price objective on the pharmaceutical behem...

HEPA stock price surged but beware of this glaring Hepion risk

May 23, 2023 07:02 PM AEST| By Invezz

Hepion Pharmaceuticals’ (NASDAQ: HEPA) stock price went parabolic on Monday after the company made an important announcement about its mid-stage trial. The shares jumpd by more than 110% and reached a high of $19.66, the highest level since Jan...

Caring for Your Portfolio: Investing in NYSE Healthcare Stocks for Long-Term Growth

May 19, 2023 06:40 PM AEST| By Team Kalkine Media

The healthcare sector is an essential and rapidly growing industry that offers attractive investment opportunities. Investing in healthcare stocks listed on the New York Stock Exchange (NYSE) allows investors to capitalize on the advancements, innova...

Watch out for these healthcare stocks in May 2023

May 08, 2023 11:52 PM AEST| By Akanksha Vashisht

Summary,Healthcare businesses are often considered as organizations that are engaged in curing ailments, but they also include REITs and specialists.,Pfizer is a household name and the company reported revenues worth US$ 18.3 billion during Q1 2023.,...